| Net revenues | 1.36M |
| Cost of revenues | -1.92M |
| Gross profit | -553.6K |
| Research and development expenses | -312.02K |
| Sales and marketing expenses | -205.65K |
| General and administrative expenses | -1.19M |
| Impairment charge | |
| Total operating expenses | -2.33M |
| Operating loss | -2.88M |
| Finance costs, net | -15.36K |
| Government grant income | 0 |
| Other (expense) / income | 229.4K |
| Loss before income taxes | -2.67M |
| Income tax benefits | 51 |
| Net loss | -2.67M |
| - Foreign currency translation adjustment | -579.45K |
| Comprehensive loss | -3.25M |
| - Basic EPS | |
| - Diluted EPS | |
| - Basic | 17.28M |
| - Diluted | 17.28M |